108 related articles for article (PubMed ID: 2744077)
1. Characterization of the antimuscarinic effect of heptane-1,7-bis-(dimethyl-3'-phthalimidopropyl ammonium bromide).
Choo LK; Mitchelson F
Eur J Pharmacol; 1989 Mar; 162(3):429-35. PubMed ID: 2744077
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the allosteric interactions of the bisquaternary heptane-1,7-bis(dimethyl-3'-phthalimidopropyl)ammonium bromide at M1 and M2 muscarine receptors.
Christopoulos A; Mitchelson F
Mol Pharmacol; 1994 Jul; 46(1):105-14. PubMed ID: 8058045
[TBL] [Abstract][Full Text] [Related]
3. Binding of the muscarine receptor antagonist heptane-1,7-bis(dimethyl-3'-phthalimidopropyl)ammonium bromide at cholinoceptor sites.
Christopoulos A; Loiacono R; Mitchelson F
Eur J Pharmacol; 1993 Jun; 246(1):1-8. PubMed ID: 8354340
[TBL] [Abstract][Full Text] [Related]
4. Antimuscarinic action of an alkane-bis-ammonium compound alone and in combination with (+)-benzetimide.
Mitchelson F
Eur J Pharmacol; 1975; 33(2):237-46. PubMed ID: 1242377
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the muscarine receptor subtype on sympathetic nerve endings in the rat caudal artery.
Shen A; Mitchelson F
Eur J Pharmacol; 1994 Feb; 252(2):167-72. PubMed ID: 7512503
[TBL] [Abstract][Full Text] [Related]
6. Binding studies on two functional cardioselective antimuscarinic compounds.
Choo LK; Mitchelson F
J Pharm Pharmacol; 1988 Apr; 40(4):288-9. PubMed ID: 2900313
[TBL] [Abstract][Full Text] [Related]
7. M2 receptor binding of the selective antagonist AF-DX 384: possible involvement of the common allosteric site.
Tränkle C; Andresen I; Lambrecht G; Mohr K
Mol Pharmacol; 1998 Feb; 53(2):304-12. PubMed ID: 9463489
[TBL] [Abstract][Full Text] [Related]
8. Interactions of agonists with an allosteric antagonist at muscarinic acetylcholine M2 receptors.
Lanzafame A; Christopoulos A; Mitchelson F
Eur J Pharmacol; 1996 Nov; 316(1):27-32. PubMed ID: 8982646
[TBL] [Abstract][Full Text] [Related]
9. Use of a spreadsheet to quantitate the equilibrium binding of an allosteric modulator.
Christopoulos A; Mitchelson F
Eur J Pharmacol; 1998 Aug; 355(1):103-11. PubMed ID: 9754944
[TBL] [Abstract][Full Text] [Related]
10. Allosteric stabilization of 3H-N-methylscopolamine binding in guinea-pig myocardium by an antidote against organophosphate intoxication.
Jepsen K; Lüllmann H; Mohr K; Pfeffer J
Pharmacol Toxicol; 1988 Sep; 63(3):163-8. PubMed ID: 3054859
[TBL] [Abstract][Full Text] [Related]
11. Displacement of [3H]oxotremorine-M binding by muscarinic antagonists in guinea-pig atrial and ileal membrane homogenates.
Choo LK; Mitchelson F
Eur J Pharmacol; 1988 Jul; 151(2):197-204. PubMed ID: 3169122
[TBL] [Abstract][Full Text] [Related]
12. Potentiation by alcuronium of the antimuscarinic effect of N-methylscopolamine in guinea pig left atria.
Maass A; Kostenis E; Mohr K
Eur J Pharmacol; 1995 Jan; 272(1):103-6. PubMed ID: 7713140
[TBL] [Abstract][Full Text] [Related]
13. Muscarinic receptor binding in the guinea pig urinary bladder.
Nilvebrant L; Sparf B
Acta Pharmacol Toxicol (Copenh); 1983 Jan; 52(1):30-8. PubMed ID: 6837322
[TBL] [Abstract][Full Text] [Related]
14. Failure of gallamine and pancuronium to inhibit selectively (-)-[3H]quinuclidinyl benzilate binding in guinea-pig atria.
Choo LK; Leung E; Mitchelson F
Can J Physiol Pharmacol; 1985 Mar; 63(3):200-8. PubMed ID: 3838695
[TBL] [Abstract][Full Text] [Related]
15. Interaction of the neuromuscular blocking drug atracurium with muscarinic acetylcholine receptors.
Musílková J; Starshinova LA; Shelkovnikov SA; Tucek S
Physiol Res; 1991; 40(3):293-304. PubMed ID: 1751476
[TBL] [Abstract][Full Text] [Related]
16. Antimuscarinic action of methoctramine, a new cardioselective M-2 muscarinic receptor antagonist, alone and in combination with atropine and gallamine.
Melchiorre C; Angeli P; Lambrecht G; Mutschler E; Picchio MT; Wess J
Eur J Pharmacol; 1987 Dec; 144(2):117-24. PubMed ID: 3436364
[TBL] [Abstract][Full Text] [Related]
17. Three allosteric modulators act at a common site, distinct from that of competitive antagonists, at muscarinic acetylcholine M2 receptors.
Lanzafame A; Christopoulos A; Mitchelson F
J Pharmacol Exp Ther; 1997 Jul; 282(1):278-85. PubMed ID: 9223565
[TBL] [Abstract][Full Text] [Related]
18. The selective antimuscarinic action of stercuronium.
Li CK; Mitchelson F
Br J Pharmacol; 1980 Oct; 70(2):313-21. PubMed ID: 6893558
[TBL] [Abstract][Full Text] [Related]
19. Kinetic studies of co-operativity at atrial muscarinic M2 receptors with an "infinite dilution" procedure.
Christopoulos A; Lanzafame A; Ziegler A; Mitchelson F
Biochem Pharmacol; 1997 Mar; 53(6):795-800. PubMed ID: 9113100
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the antimuscarinic and other actions of proadifen in-vitro.
Choo LK; Malta E; Mitchelson F
J Pharm Pharmacol; 1986 Dec; 38(12):898-901. PubMed ID: 2880963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
